2011 - Transplantomics and Biomarkers in Transplantation

This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Techniques Showcase Presentation

1.3 - Potential Role of Novel Imaging Modalities in Transplantation

Presenter: Reza, Razavi, London, UK
Authors: Reza Razavi

Potential Role of Novel Imaging Modalities in Transplantation

Reza Razavi, King's College London, London, UK

Imaging the mechanisms involved in Transplantation rejection and the therapies being developed to induce tolerance will have substantial benefits outlined below. Firstly, it should allow much better understanding of the underlying biology at an organ or system level and allow the testing of hypotheses that would otherwise be difficult or expensive to address. Secondly, with the relatively lower bar in taking novel imaging agents into man. The clinical translation of these techniques will provide new biological biomarkers to assess first in man therapies for transplant tolerance. Thirdly, personalising the therapeutic cocktail being used in individual patients on biological end points often requires invasive procedures such as organ biopsies. Novel imaging may allow a non invasive way of optimising these treatments. In this presentation, I will discuss some potential methods and preliminary results of novel imaging agents and techniques using MRI, PET or SPECT to look at activated complement, cellular therapies (dendritic cells and T Regs) in preclinical models and the clinical application of an MR technique for looking at transplant rejection.

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6